Harbor Investment Advisory’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
VCM
VPM
Harbor Investment Advisory's CRL Position: Q1 2026 in Review
Harbor Investment Advisory sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 26 shares — an estimated $5.19K sold.
Harbor Investment Advisory first reported a position in CRL in Q1 2021 and held it in 20 quarters. The position peaked at $223K in Q4 2023. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Harbor Investment Advisory reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
- Harbor Investment Advisory sold 26 Charles River Laboratories shares in Q1 2026, an estimated $5.19K.
- Harbor Investment Advisory first reported a position in Charles River Laboratories in Q1 2021 and held it in 20 quarters.
- Harbor Investment Advisory's Charles River Laboratories position peaked at $223K in Q4 2023.
- 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Harbor Investment Advisory's 13F filing for Q1 2026, filed 23 Apr 2026.